Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03553680 · ClinicalTrials.gov registry record · NA

An Emotion-Focused Intervention for Glycemic Control in T2D

A NA study of Type2 Diabetes, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03553680 is a NA study of Type2 Diabetes that has completed, run by University of Chicago. The registered enrollment target is 20 participants, below the 47,822-participant average among 20 other Type2 Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03553680, a NA study of Type2 Diabetes, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this proposed project is to collect pilot data using an Emotion-Focused CBT Psycho-social Intervention i individuals with T2D to obtain the effect sizes on hypothesized changes in Negative Emotionality, Diabetes Distress, and HbA1c values that will be needed for a more appropriately sized clinical trial for an RO1 submission to the National Institutes of Health.

Conditions Studied

Interventions

  • BEHAVIORAL Emotion-Focused CBT

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2017-10-20
Est. Completion 2018-10-19
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT03553680

The ClinicalTrials.gov registry entry for NCT03553680 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 47,822-participant average among 20 other Type2 Diabetes trials with a reported enrollment target (100% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Emotion-Focused CBT is the first listed.

NCT03553680 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03553680 about?

NCT03553680 is a clinical study titled "An Emotion-Focused Intervention for Glycemic Control in T2D". The primary aim of this proposed project is to collect pilot data using an Emotion-Focused CBT Psycho-social Intervention i individuals with T2D to obtain the effect sizes on hypothesized changes in Negative Emotionality, Diabetes Distress, and HbA1c values that will be needed for a more appropriate...

What is the current status of trial NCT03553680?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-10-20. Estimated completion is 2018-10-19.

What conditions does trial NCT03553680 study?

This clinical trial studies the following conditions: Type2 Diabetes.

What interventions are being tested in trial NCT03553680?

The interventions under investigation include: Emotion-Focused CBT (BEHAVIORAL).

Who is sponsoring clinical trial NCT03553680?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03553680 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.